iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionSP Asset Management LLC
Latest Disclosed Ownership41,573 shares
Latest Disclosed Value $ 7,019,625
SP Asset Management LLC reports 1.80% decrease in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 6, 2026 - SP Asset Management LLC filed a 13F-HR form disclosing ownership of 41,573 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $7,019,625 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 28, 2026 disclosing 42,335 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of -1.80% during the quarter. The current value of the position is $5,448,142 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 41,573 -762 -1.80 7,020 -1.75 0.6193
2026-01-28 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 42,335 -212 -0.50 7,145 16.31 0.5648
2025-11-04 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 42,547 -4,593 -9.74 6,143 3.00 0.4875
2025-08-06 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 47,140 -4,050 -7.91 5,964 -8.92 0.4921
2025-05-08 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 51,190 -1,846 -3.48 6,547 -6.62 0.5772
2025-02-06 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 53,036 21 0.04 7,012 -9.17 0.5880
2024-11-12 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 53,015 71 0.13 7,719 6.22 0.6409
2024-08-07 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 52,944 -2,623 -4.72 7,267 -4.68 0.6614
2024-05-08 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 55,567 -280 -0.50 7,625 0.50 0.7094
2024-02-07 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 55,847 4,811 9.43 7,587 21.55 0.7776
2023-11-03 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 51,036 -226 -0.44 6,241 -4.10 0.7013
2023-08-03 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 51,262 2 0.00 6,508 -1.69 0.7261
2023-05-05 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 51,260 -10,260 -16.68 6,621 -18.03 0.8119
2023-02-01 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 61,520 61,520 8,077 1.0812
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.